Immune Checkpoint Inhibitors in Prostate Cancer

SIMPLE SUMMARY: Metastatic prostate cancer is an incurable disease with limited treatment options. Immunotherapy has demonstrated significant success in multiple cancer types but efforts to harness its benefit in prostate cancer have so far largely been unsuccessful. In this review, we analyze the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Venkatachalam, Shobi, McFarland, Taylor R., Agarwal, Neeraj, Swami, Umang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125096/
https://www.ncbi.nlm.nih.gov/pubmed/34063238
http://dx.doi.org/10.3390/cancers13092187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125096/
https://www.ncbi.nlm.nih.gov/pubmed/34063238
http://dx.doi.org/10.3390/cancers13092187

Ejemplares similares